This Phase 1/2 randomized study sponsored by the U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is looking at how well pioglitazone improves blood vessel function and decreases blood vessel inflammation for patients with lupus. The study is being conducted at the NIH Clinical Center in Bethesda, Maryland.
To Learn More Contact
Call 800-411-1222 ext or firstname.lastname@example.org
ClinicalTrials.gov identifier: NCT02338999